Clinical trials
-
Exercise testing in DMD -
Platelet Function Testing Substudy - Investigator
- Larisa H Cavallari
-
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy鈥�
- Investigator
- Ibrahim Nassour
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy for Limited mCRC(ERASur) This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients鈥�
- Investigator
- Kathryn E Hitchcock
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing the Role ctDNA in Guiding Immunotherapy After Bladder Removal for Bladder CA Tx (MODERN ) This phase II/III trial examines whether patients who have undergone surgical removal of bladder, but require an additional treatment called immunotherapy to help prevent their bladder cancer from coming back, can be identified by a blood test. Many鈥�
- Investigator
- Jonathan A Chatzkel
- Ages
- 18 Years - N/A
- Sexes
- All
-
Testing the Addition of an ADC(TRC102) to the Usual Chemo Tx During RT for Stage III Non-Squam NSCLC This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvalumab works better than the usual care treatment鈥�
- Investigator
- Tithi Biswas
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment o This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after鈥�
- Investigators
- Brian Stover, William Slayton
- Ages
- N/A - 22 Years
- Sexes
- All
-
Testing Triapine w/ Targeted Radiation-based LU177 vs Lu177 alone in pts w/ metastatic NETs This phase II trial compares the effect of adding triapine to lutetium Lu 177 dotatate versus lutetium Lu 177 dotatate alone (standard therapy) in shrinking tumors or slowing tumor growth in patients with neuroendocrine tumors that have spread from鈥�
- Investigator
- Kathryn E Hitchcock
- Ages
- 18 Years - N/A
- Sexes
- All
-
TAPUR: Testing FDA Approved Drugs That Target Specific Abnormal Tumor Genes in Pts w/Advanced Cancer The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. Note: Due to鈥�
- Investigator
- Thomas J George
- Ages
- 12 Years - N/A
- Sexes
- All
-
BLUE-C The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.
- Ages
- 40 Years - N/A
- Sexes
- All